2020年2月20日

CareSignal宣布投资4战略一致的医疗技术风险投资基金CareSignal(以前称为Epharmix)宣布投资4战略一致的医疗技术风险资本基金。CareSignal是一个访问远程病人监控平台,提高付款人在价值关怀和提供者的性能吸引并识别风险升高的病人。和两个投资者——OSF企业和UnityPoint健康企业customer-partners病人使用CareSignal远程监控和参与解决方案。加上OSF CareSignal先前投资企业正在扩大。Nueterra资本和1984年企业提供深度的结合技术经验,对国家医疗生态系统的关系,和医疗业务知识。“这些投资者代表CareSignal最好capital partners,”布莱克Marggraff说CareSignal的首席执行官和创始人之一。“我们正在积极部署额外的资金向销售和营销作为我们扩大全国新支付和大型供应商合作伙伴。专业知识,连接和资本从OSF, UnityPoint Nueterra和1984使CareSignal增长更快,影响医疗stakeholders-customers和病人,有最获得。“广告OSF企业风险投资总监玛雅希夫指出,风险投资公司很高兴继续CareSignal的财政支持。“作为一个先锋在成规采用创新的解决方案,OSF医疗是骄傲的是一个日益增长的客户和公司的合作伙伴。他们的技术增强了我们与病人沟通的能力,对他们的需求。 Improved patient outcomes along with a compelling value proposition make this a solution of choice for us,” added Taneja. Clint Myers, vice president of Nueterra Capital, pointed out that his venture firm has deep experience in healthcare administration, value-oriented health innovations, and digital health startups. “Nueterra chose to invest in CareSignal because of the company’s traction with evidence-based solutions adopted by systems across the nation; technology, including defensible intellectual property and an aggressive focus on machine learning; and timing, as the industry shifts to true value-based care,” explained Myers. 1984 Ventures general partner Ramy Adeeb said that his firm focuses on companies using software to solve real-world problems at scale and they could not be more excited about their investment in CareSignal. “By using technology to prioritize and engage with rising-risk patients in real-time, CareSignal is able to improve outcomes and reduce cost in some of healthcare’s most challenging and expensive areas, including heart failure, hypertension, and diabetes,” stated Farzad Soleimani, MD, MBA, healthcare partner at 1984 Ventures.